Clarkston Capital Partners’s Charles River Laboratories CRL Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2015
Q4 | – | Sell |
-143,433
| Closed | -$9.11M | – | 132 |
|
|
2015
Q3 | $9.11M | Buy |
143,433
+1,820
| +1% | +$116K | 0.83% | 45 |
|
|
2015
Q2 | $9.96M | Buy |
141,613
+19,441
| +16% | +$1.37M | 1.02% | 42 |
|
|
2015
Q1 | $9.69M | Buy |
122,172
+13,487
| +12% | +$1.07M | 1.07% | 37 |
|
|
2014
Q4 | $6.92M | Buy |
108,685
+2,025
| +2% | +$129K | 1.05% | 32 |
|
|
2014
Q3 | $6.37M | Buy |
106,660
+6,565
| +7% | +$392K | 1.1% | 30 |
|
|
2014
Q2 | $5.36M | Sell |
100,095
-1,890
| -2% | -$101K | 0.99% | 34 |
|
|
2014
Q1 | $6.15M | Buy |
101,985
+45,635
| +81% | +$2.75M | 1.23% | 28 |
|
|
2013
Q4 | $2.99M | Buy |
56,350
+15,125
| +37% | +$802K | 1.16% | 29 |
|
|
2013
Q3 | $1.91M | Buy |
41,225
+8,220
| +25% | +$380K | 0.92% | 36 |
|
|
2013
Q2 | $1.36M | Buy |
+33,005
| New | +$1.36M | 0.75% | 41 |
|